Fact based stock research
Qiagen (NYSE:QGEN)

NL0012169213

Qiagen stock research in summary

qiagen.com


Qiagen shares have a market-typical stock price level. While they show above average growth, they are poor value, and are riskily financed. We recommend evaluating whether the future of the company Qiagen is typical for this industry which the market average price level of the shares suggests. If you believe that the future of the company is above average, that could be an argument for buying the shares and vice versa.


Latest Obermatt Ranks


Country Netherlands
Industry Life Sciences Tools & Services
Index TecDAX, MDAX
Size class Large

September 10, 2021. Stock data may be delayed. Login to get the most recent research.


Achievements

Top 10 Stock


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Qiagen from September 10, 2021.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.